(2011) Wild-Type Measles Virus is Intrinsically Dual-Tropic.

(2019) Enteroviruses: A Gut-Wrenching Game of Entry, Detection, and Evasion.

(2019) Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus.

(2022) Antiviral effects of azithromycin: A narrative review.

(2022) Enterovirus A71 antivirals: Past, present, and future.

(2020) Using Diverse Model Systems to Define Intestinal Epithelial Defenses to Enteric Viral Infections.

(2019) Host Cellular Receptors for the Peste des Petits Ruminant Virus.

(2016) TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.

(2024) Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy.

(2020) Landscape of natural killer cell activity in head and neck squamous cell carcinoma.

(2023) Role of the Alteration in Calcium Homeostasis in Cell Death Induced by Clostridioides difficile Toxin A and Toxin B.

(1998) New assays for the quality control of live oral poliovirus vaccine.

(1998) Retrograde transport of intact poliovirus through the axon via the fast transport system.

(1997) Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation.

(1997) Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.

(1997) Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA.

(1993) Bidirectional entry of poliovirus into polarized epithelial cells.

(1994) Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence.

(1994) The human poliovirus receptor alpha is a serine phosphoprotein.

(1994) Cleavage site of the poliovirus receptor signal sequence.

(1995) Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.

(1995) Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.

(2023) Morbillivirus: A highly adaptable viral genus.

(2021) Evaluation and validation of next-generation sequencing to support lot release for a novel type 2 oral poliovirus vaccine.

(2018) Replacement of primary monkey kidney cells by L20B cell line in the test for effective inactivation of inactivated poliovirus vaccine.

(2016) Methods for the Quality Control of Inactivated Poliovirus Vaccines.

(2016) A Transgenic Mouse Model of Poliomyelitis.

(2015) Identification of new genotype of Echovirus 19 from children with Acute Flaccid Paralysis in Pakistan.

(2015) An Insight into Recombination with Enterovirus Species C and Nucleotide G-480 Reversion from the Viewpoint of Neurovirulence of Vaccine-Derived Polioviruses.

(2015) A single chimpanzee-human neutralizing monoclonal antibody provides post-exposure protection against type 1 and type 2 polioviruses.

(2009) The interaction of hepatitis A virus (HAV) with soluble forms of its cellular receptor 1 (HAVCR1) share the physiological requirements of infectivity in cell culture.

(2005) Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice.

(2003) Gene expression in the muscle and central nervous system following intramuscular inoculation of encapsidated or naked poliovirus replicons.

(1992) N glycosylation of the virus binding domain is not essential for function of the human poliovirus receptor.

(1992) A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain.

(2002) The neuropathology observed in wild-type mice inoculated with human poliovirus mirrors human paralytic poliomyelitis.

(2002) Immunofluorescence analysis of poliovirus receptor expression in Peyers patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection.

(2001) Comparison of neuropathogenicity of poliovirus type 3 in transgenic mice bearing the poliovirus receptor gene and cynomolgus monkeys.

(1999) Poliomyelitis in intraspinally inoculated poliovirus receptor transgenic mice.

(2023) Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3.

(2023) Asymptomatic immunodeficiency-associated vaccine-derived poliovirus infections in two UK children.

(2022) History of the Wastewater Assessment of Polio and Non-Polio Enteroviruses in the Slovak Republic in 1963-2019.

(2021) Insight Into an Outbreak of Canine Distemper Virus Infection in Masked Palm Civets in China.

(2021) Live Viral Vaccine Neurovirulence Screening: Current and Future Models.

(2021) Computational Analysis Reveals a Critical Point Mutation in the N-Terminal Region of the Signaling Lymphocytic Activation Molecule Responsible for the Cross-Species Infection with Canine Distemper Virus.

(2020) Measles Virus Hemagglutinin Protein Establishes a Specific Interaction With the Extreme N-Terminal Region of Human Signaling Lymphocytic Activation Molecule to Enhance Infection.

(2020) Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence.

(2019) Understanding Enterovirus D68-Induced Neurologic Disease: A Basic Science Review.

(2018) Proteogenomic Identification of a Novel Protein-Encoding Gene in Bovine Herpesvirus 1 That Is Expressed during Productive Infection.

(2018) Fc engineering of anti-Nectin-2 antibody improved thrombocytopenic adverse event in monkey.

(2017) Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.

(2016) Mapping the evolutionary trajectories of morbilliviruses: what, where and whither.

(2016) Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination.

(2015) PyIgClassify: a database of antibody CDR structural classifications.

(2014) The tumor-associated marker, PVRL4 (nectin-4), is the epithelial receptor for morbilliviruses.

(2012) Immunopathogenic and neurological mechanisms of canine distemper virus.

(2012) Poliovirus trafficking toward central nervous system via human poliovirus receptor-dependent and -independent pathway.

(2011) Measles virus hemagglutinin: structural insights into cell entry and measles vaccine.

(2011) Oncolytic poliovirus against malignant glioma.

(2010) Preparing an oncolytic poliovirus recombinant for clinical application against glioblastoma multiforme.

(2008) Recombinant oncolytic poliovirus eliminates glioma in vivo without genetic adaptation to a pathogenic phenotype.

(2009) Use of intracytoplasmic sperm injection (ICSI) to generate transgenic animals.

(2000) Defects in nuclear and cytoskeletal morphology and mitochondrial localization in spermatozoa of mice lacking nectin-2, a component of cell-cell adherens junctions.

(2021) Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.

(2016) Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus.

(2013) Dual role of commensal bacteria in viral infections.

(2012) Evidence for an enterovirus as the cause of encephalitis lethargica.

(2015) Tissue instruction for migration and retention of TRM cells.

(2023) The application of autologous cancer immunotherapies in the age of memory-NK cells.

(2023) NK cells are never alone: crosstalk and communication in tumour microenvironments.

(2007) Structures of T Cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family.

(2022) Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders.

(2023) Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E-based Antibody-Drug Conjugate for Treatment of Nectin-4-expressing Cancers.

(2016) Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma.

(2015) Involvement of a C-terminal motif in the interference of primate lentiviral Vpu proteins with CD1d-mediated antigen presentation.

(2009) Making it to the synapse: measles virus spread in and among neurons.

(2022) Plant-Derived Human Vaccines: Recent Developments.

(2019) Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses.

(2019) The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.

(2018) Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds.

(2017) Novel Concepts for HIV Vaccine Vector Design.

(2022) Expression of CD226 is upregulated on Tr1 cells from neuromyelitis optica spectrum disorder patients.

(2021) Experimental Methods to Study the Pathogenesis of Human Enteric RNA Viruses.

(2020) Current status and future perspectives of HLA-edited induced pluripotent stem cells.

(2014) Animal models of enterovirus 71 infection: applications and limitations.

(2014) Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo.

(2012) Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases.

(2009) Oncolytic viral therapy of malignant glioma.

(2023) Nectin-4 is frequently expressed in primary salivary gland cancer and corresponding lymph node metastases and represents an important treatment-related biomarker.

(2014) Phocine distemper virus: current knowledge and future directions.

(2023) Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells.

(2020) Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy.

(2019) The Commensal Microbiota and Viral Infection: A Comprehensive Review.

(2019) The viral protein corona directs viral pathogenesis and amyloid aggregation.

(2021) The New Kid on the Block: HLA-C, a Key Regulator of Natural Killer Cells in Viral Immunity.